Filing Details
- Accession Number:
- 0001209191-19-017304
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-06 16:07:30
- Reporting Period:
- 2019-03-05
- Accepted Time:
- 2019-03-06 16:07:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1606645 | Foamix Pharmaceuticals Ltd. | FOMX | Medicinal Chemicals & Botanical Products (2833) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1759703 | T. Matthew Wiley | C/O Foamix Pharmaceuticals Ltd. 2 Holzman Street Rehovot L3 7670402 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-03-05 | 13,440 | $3.76 | 63,440 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.725 to $3.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
Billionaire Hedge Funds
